Regarding monitoring of hematological parameters in stable GD patients on long‐term treatment who develop persistent anemia, panelists agreed that it should include determination of reticulocyte count, serum levels of vitamin B12, folic acid, iron and ferritin, and haptoglobin (Table 2). Here, HP is linked to anemia.